CVS Health Corporation’s Stock Price Soars to $62.45, Recording a Positive Leap of 1.81%

CVS Health Corporation (CVS)

62.45 USD +1.11 (+1.81%) Volume: 9.15M

CVS Health Corporation’s stock price is currently valued at 62.45 USD, exhibiting a positive trend with a trading session increase of 1.81%. The robust trading volume of 9.15M underscores the market’s interest in CVS, which has seen an impressive YTD percentage change of +39.12%, indicating a strong performance in the stock market.

Latest developments on CVS Health Corporation

Recent stock movements for CVS Health Corp (NYSE:CVS) have been influenced by various key events. The Employees Retirement System of Texas purchased 39,060 shares, while Novem Group made a new investment in the company. Ameriflex Group Inc. bought 4,380 shares, Leigh Baldwin & CO. LLC acquired 6,240 shares, and Vega Investment Solutions purchased a new stake. On the other hand, Toronto Dominion Bank reduced its stake in CVS Health Corp. Heck Capital Advisors LLC invested $185,000 in the company, and Mackenzie Financial Corp acquired 68,144 shares. Investors are also comparing CVS Health Corp with other healthcare stocks like Cigna and DHR to determine the better value stock to own at this time.

CVS Health Corporation on Smartkarma

Analysts on Smartkarma have been closely covering Cvs Health Corp, providing valuable insights for investors. Baptista Research, in their report titled “CVS Health Powers Into Medicare & Medicaid with Aggressive Aetna Expansion Strategy; What Lies Ahead?”, expressed a bullish sentiment. They highlighted the company’s strong start to the year, with a 7% increase in first-quarter revenue and adjusted earnings per share reaching $2.25. Additionally, CVS Health adjusted its full-year 2025 guidance upwards, showing confidence in its performance.

Another report by Baptista Research, titled “CVS Health: $97.7 Billion Revenue and a New CEO – Can It Overcome Industry Challenges?”, also expressed a bullish sentiment. The report discussed how CVS Health saw a significant turnaround with better-than-expected quarterly earnings, leading to a 14.8% rise in stock price. Despite challenges in 2024, including regulatory scrutiny and financial pressures, the company’s new CEO aims to restore investor confidence and execute a strategic recovery plan.

A look at CVS Health Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, CVS Health Corp seems to have a positive long-term outlook. With top scores in both value and dividend factors, investors may see potential for strong returns and stable income. However, the company’s growth, resilience, and momentum scores are slightly lower, indicating some areas for improvement in the future. Overall, CVS Health Corp’s integrated pharmacy health care services and widespread presence across the U.S. position it well in the healthcare industry.

CVS Health Corporation is an integrated pharmacy health care provider that offers a range of services including pharmacy benefit management, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. With high scores in value and dividend factors, the company may be seen as a solid investment choice for those looking for stability and potential returns. While growth, resilience, and momentum scores are not as high, CVS Health Corp’s established presence in the market suggests a promising outlook for the company in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma